GlassScriptPhysician profile
Rena Khanukayeva
NPI 1255358164
$18,373.47
in general payments reported to CMS, 2019-2025
55 companies · $2,743 in 2025
The $2,743 reported for 2025 was more than what 98% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,959 · 2020: $2,426 · 2021: $3,304 · 2022: $2,486 · 2023: $2,732 · 2024: $2,724 · 2025: $2,743.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,198.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,711.85 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $2,600.20 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $2,484.71 | 2019-2025 | Xifaxan, Trulance |
| Glaxosmithkline, LLC. | $1,203.66 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Amgen INC. | $1,008.73 | 2019-2025 | Otezla, Repatha, Evenity |
| Amarin Pharma, INC. | $928.56 | 2019-2023 | |
| Lilly USA, LLC | $645.24 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Pfizer INC. | $622.26 | 2019-2025 | |
| Nestle Healthcare Nutrition INC. | $596.11 | 2020-2023 | |
| Scilex Pharmaceuticals INC. | $448.63 | 2021-2025 | Ztlido |
| Boehringer Ingelheim Pharmaceuticals, INC. | $380.72 | 2019-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $376.17 | 2023-2025 | |
| Esperion Therapeutics, INC. | $365.80 | 2020-2024 | Nexletol |
| Takeda Pharmaceuticals U.S.A., INC. | $349.65 | 2019-2025 | Vpriv, Trintellix |
| Ardelyx, INC. | $331.54 | 2023-2025 | Ibsrela |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aimmune Therapeutics, INC. | $325.14 | 2024-2025 | Zenpep |
| Allergan, INC. | $308.72 | 2019-2020 | |
| Astellas Pharma US INC | $291.39 | 2019-2025 | Veozah, Myrbetriq |
| Merck Sharp & Dohme LLC | $264.83 | 2019-2023 | Verquvo |
| Kowa Pharmaceuticals America, INC. | $241.08 | 2019-2025 | Zoryve |
| Axsome Therapeutics, INC. | $170.01 | 2023-2025 | Symbravo, Auvelity |
| Novo Nordisk INC | $162.73 | 2024-2025 | Ozempic, Rybelsus |
| Vivus LLC | $143.49 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $121.34 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $118.07 | 2021-2022 | |
| Impel Pharmaceuticals INC. | $104.94 | 2023 | Trudhesa |
| Almatica Pharma LLC | $89.15 | 2021 | |
| Endo Pharmaceuticals INC. | $83.63 | 2020-2024 | Nascobal |
| Sanofi-Aventis U.S. LLC | $59.87 | 2021 | |
| Gilead Sciences, INC. | $58.39 | 2019-2022 | |
| Horizon Therapeutics Plc | $57.72 | 2021 | |
| Ironwood Pharmaceuticals, INC | $56.38 | 2021-2023 | Linzess |
| Intra-Sana Laboratories | $51.09 | 2025 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Arbor Pharmaceuticals, INC. | $49.01 | 2019-2022 | |
| Otsuka America Pharmaceutical, INC. | $46.48 | 2023 | Rexulti |
| Medtronic, INC. | $44.26 | 2023 | Corevalve Evolut R |
| Ibsa Pharma INC. | $41.52 | 2022-2024 | Tirosint, Licart, Tirosint |
| Corcept Therapeutics | $38.35 | 2024 | Korlym |
| Shield Therapeutics INC | $37.86 | 2025 | |
| Genentech USA, INC. | $32.94 | 2020 | |
| Dermira, INC. | $32.50 | 2020 | |
| Lundbeck LLC | $28.90 | 2023 | Rexulti |
| E.R. Squibb & Sons, L.L.C. | $25.68 | 2024 | Camzyos |
| Biohaven Pharmaceuticals, INC. | $25.20 | 2020 | |
| Exact Sciences Corporation | $25.00 | 2023 | Cologuard Collection Kit |
| Cumberland Pharmaceuticals, INC. | $22.82 | 2025 | Kristalose |
| Verona Pharma, INC. | $22.04 | 2025 | Ohtuvayre |
| Intuity Medical INC | $21.36 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Vbi Vaccine (Delaware) INC. | $20.00 | 2023 | Prehevbrio |
| Sunovion Pharmaceuticals INC. | $19.68 | 2022 | |
| Eyevance Pharmaceuticals LLC | $18.80 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $16.47 | 2022 | |
| Eisai INC. | $15.47 | 2022 | |
| Amneal Pharmaceuticals LLC | $13.72 | 2024 | Unithroid |
| Hikma Pharmaceuticals USA | $13.61 | 2023 | Mitigare, Ryaltris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rena Khanukayeva listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.